Document is current
Any future updates will be listed below
-
Authors
Okagawa, Yutaka
Kubo, Tomohiro
Ariga, Shin
Suzuki, Norito
Tanabe, Hiroki
Sogabe, Susumu
Ishiguro, Atsushi
Ikeda, Tatsuru
Minami, Shinya
Hirakawa, Masahiro
Kinoshita, Ichiro
Takada, Kohichi https://orcid.org/0000-0002-1393-9442
- License Information
-
More Information
Article History
Received: 17 July 2025
Accepted: 21 September 2025
First Online: 11 October 2025
Declarations
:
: Dr. Ichiro Kinoshita has received lecture fees from MSD K.K., Bayer Yakuhin, Ltd., Takeda Pharmaceutical Company Limited, Konica Minolta REALM, Chugai Pharmaceutical Co., Ltd., Novartis Pharma K.K., Guardant Health Japan Corp., and Pfizer Japan Inc., and research funding from Konica Minolta REALM, Eisai Co., Ltd., Daiichi Sankyo Co., Ltd., and Chugai Pharmaceutical Co., Ltd., unrelated to this study. Dr. Kohichi Takada has received lecture fees from Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Janssen Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., Eli Lilly and Company, Sanofi, MSD K.K., Takeda Pharmaceutical Company Limited, Zeria Pharmaceutical Co., Ltd., and Sysmex Corporation, unrelated to this study. Other authors declare no conflicts of interest.
